HHC
ENZ

Hutchin Hill Capital’s Enzo Biochem, Inc. ENZ Stock Holding History

Hutchin Hill Capital’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$231K Buy
+28,400
New +$271K 0.06% 315
2017
Q3 		– Sell
-43,900
Closed -$485K – 998
2017
Q2 		$485K Buy
+43,900
New +$409K 0.02% 676

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

Hutchin Hill Capital's ENZ Position: Q4 2017 in Review

Hutchin Hill Capital opened a new position in Enzo Biochem, Inc. (ENZ) in Q4 2017: 28,400 shares worth $231K. The stake represents 0.06% of the portfolio and ranks #315 among its holdings. This is a return to the name: Hutchin Hill Capital previously reported a position in ENZ as recently as Q2 2017.

Hutchin Hill Capital first reported a position in ENZ in Q2 2017 and has held it in 2 quarters since. The position peaked at $485K in Q2 2017. 115 funds tracked by Wall St. Rank hold ENZ as of Q4 2017.

  • Hutchin Hill Capital held 28,400 shares of Enzo Biochem, Inc. worth $231K as of Q4 2017.
  • Enzo Biochem, Inc. was a new Hutchin Hill Capital position in Q4 2017.
  • Enzo Biochem, Inc. made up 0.06% of Hutchin Hill Capital's portfolio in Q4 2017, its #315 holding.
  • Hutchin Hill Capital first reported a position in Enzo Biochem, Inc. in Q2 2017 and has held it in 2 quarters since.
  • Hutchin Hill Capital's Enzo Biochem, Inc. position peaked at $485K in Q2 2017.
  • 115 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2017.

Based on Hutchin Hill Capital's 13F filing for Q4 2017, filed 12 Feb 2018.